Vimarsana
Biggest News Aggregation in the World

Page 3 - Neuronetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuronetics Inc Today - Breaking & Trending Today

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital - Vimarsana News

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Lack of early symptom improvement is not predictive of final responder statusMALVERN, Pa., April 10, 2024 -- Neuronetics, Inc. , a medical technology company focused on designing, developing, and...

Top 5 Health Care Stocks That May Plunge In March - Mesoblast (NASDAQ:MESO), Inozyme Pharma (NASDAQ:INZY) - Vimarsana News

Top 5 Health Care Stocks That May Plunge In March - Mesoblast (NASDAQ:MESO), Inozyme Pharma (NASDAQ:INZY)

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Neurostar cleared for use in adolescent depression - Vimarsana News

Neurostar cleared for use in adolescent depression

The U.S. FDA granted Neuronetics Inc. clearance for use of its Neurostar advanced therapy as an adjunctive treatment of major depressive disorder in patients aged 15 to 21, making it the first transcranial magnetic stimulation treatment (TMS) cleared for this age group, the company said.

Neuronetics (NASDAQ:STIM) Given Market Perform Rating at William Blair - Vimarsana News

Neuronetics (NASDAQ:STIM) Given Market Perform Rating at William Blair

William Blair reissued their market perform rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research note published on Tuesday morning, RTT News reports. Separately, Piper Sandler reaffirmed an overweight rating and issued a $8.00 target price (up from $7.00) on shares of Neuronetics in a research note on Wednesday, March 6th. Read […]

FDA Approves NeuroStar TMS for Treatment of MDD in Adolescents - Vimarsana News

FDA Approves NeuroStar TMS for Treatment of MDD in Adolescents

This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.